Monthly return of equity issuer on movements in securities for the month ended 30 september 2026
Filed with HKEX · Stock code 1093 · · 10 pages · English
Earlier from Cspc Pharmaceutical
- Voluntary announcement - results of phase iii clinical study of efmedaglutide alfa injection in combination with metformin in chinese adult patients with type 2 diabetes mellitus presented in a short oral discussion at the 62nd annual meeting of the european association for the study of diabetes (easd 2026)
- Voluntary announcement - phase ib clinical trial of jmt206 injection for weight management in adult patients with overweight or obesity officially initiated at the first study centre in china
- Voluntary announcement - recombinant herpes zoster vaccine (sys6052) obtains clinical trial approval in the U.S.
- Voluntary announcement - sys6077 injection obtains clinical trial approval in china